1 / 34

When Using DOPPS Slides

When Using DOPPS Slides. DOPPS Slide Use Guidelines. Facility Hemodialysis Vascular Access Use and Mortality in Countries Participating in DOPPS: An Instrumental Variable Analysis. Introduction. DOPPS Background (1). DOPPS Background (2). Methods – Study Sample.

zach
Download Presentation

When Using DOPPS Slides

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. When Using DOPPS Slides

  2. DOPPS Slide Use Guidelines

  3. Facility Hemodialysis Vascular Access Use and Mortality in Countries Participating in DOPPS: An Instrumental Variable Analysis

  4. Introduction

  5. DOPPS Background (1)

  6. DOPPS Background (2)

  7. Methods – Study Sample

  8. Methods- Statistical Analysis

  9. Methods- Statistical Analysis (2)

  10. Table 1. Mean Patient Characteristic and Laboratory Values for Patients Dialyzing With Either an AVF, Graft, or Catheter at Time of Entry into DOPPS I or II (1)

  11. Table 1. Mean Patient Characteristic and Laboratory Values for Patients Dialyzing With Either an AVF, Graft, or Catheter at Time of Entry into DOPPS I or II (2)

  12. Table 2. Mortality Risk Associated with Type of Vascular Access Used for HD by a Patient at Time of Study Entry (1)

  13. Table 2. Mortality Risk Associated with Type of Vascular Access Used for HD by a Patient at Time of Study Entry (2)

  14. Fig. 1A: Distribution of Percentages of Facility Patients Using a Catheter, by Region in DOPPS II

  15. Fig. 1B: Distribution of Percentages of Facility Patients Using a Graft, by Region in DOPPS II

  16. Fig. 1C: Distribution of Percentages of Facility Patients Using an AVF, by Region in DOPPS II

  17. Table 3. Mean Patient Characteristics and Laboratory Values Significantly Associated with Different Levels of Facility Case-mix Adjusted Catheter Use (1)

  18. Table 3. Mean Patient Characteristics and Laboratory Values Significantly Associated with Different Levels of Facility Case-mix Adjusted Catheter Use (2)

  19. Table 4: Mean Patient Characteristic and Laboratory Values Significantly Associated With Different Levels of Facility Case-mix Adjusted Graft Use (1)

  20. Table 4: Mean Patient Characteristic and Laboratory Values Significantly Associated With Different Levels of Facility Case-mix Adjusted Graft Use (2)

  21. Fig. 2: Adjusted Mortality Risk by Approximate Quintiles of Case-mix Adjusted Facility Catheter and Graft Use

  22. Table 5: Cox Models of Mortality Risk in Relationship to Adjusted Facility Percentages of Catheter Use and Graft Use Compared with Facility AVF Use (1)

  23. Table 5: Cox Models of Mortality Risk in Relationship to Adjusted Facility Percentages of Catheter Use and Graft Use Compared with Facility AVF Use (2)

  24. Fig. 3: Adjusted Mortality Risk by Categories of Case-mix Adjusted Facility Catheter and Graft Use as a Percentage of Permanent VA Use

  25. Table 6: Cox Models of Mortality Risk in Relationship to Adjusted Facility Percentage of Catheter Use Compared With Facility AVF Plus Graft Use (1)

  26. Table 6: Cox Models of Mortality Risk in Relationship to Adjusted Facility Percentage of Catheter Use Compared With Facility AVF Plus Graft Use (2)

  27. Fig. 4A: Relative Risk of All-Cause Hospitalization by Case-mix Adjusted Facility Catheter or Graft Use

  28. Fig. 4B: Relative Risk of Infection-Related Hospitalization by Case-mix Adjusted Facility Catheter or Graft Use

  29. Fig. 4C: Relative Risk of Access Related Hospitalization by Case-mix Adjusted Facility Catheter or Graft Use

  30. Fig. 5A: Case-mix Adjusted Mortality Risk for HD Patients in the US Versus Europe: With and Without Adjustment for Differences in Facility Vascular Access Use

  31. Conclusions

  32. Conclusions (2)

  33. Acknowledgements

More Related